Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib ...

INAB READ THE FULL INAB RESEARCH REPORT Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc ...

The battle over Liberia's railway infrastructure has intensified as ArcelorMittal Liberia (AML) has formally warned the Government of Liberia (GOL) of potential legal action if it proceeds with a ...

Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company and world leader in developing N-myristoyltransferase inhibitors (NMTis) for cancer. Oral zelenirstat is under ...

In an analysis of 1,034 fit adults aged 70 years and younger, age and genetic features were identified as the factors most ...

ArcelorMittal marked two decades of investment, growth, and contributions to the country's economy and mining sector.By: Kruah ThompsonMonrovia, March 17, 2025/ Global steel giant ArcelorMittal marked ...

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat ...

DGQEX, a globally renowned cryptocurrency trading platform, announced another significant breakthrough in its compliance ...

Darknet vendors increasingly use DeFi for laundering as authorities tighten KYC and AML rules on CEXs. XMR is replacing BTC for privacy.

ArcelorMittal Liberia (AML) is celebrating 20 years of operations in Liberia with a major milestone—the launch of its over $2 billion Phase II Expansion Project. The company’s investment is set to ...

Cryptocurrency Founder and CEO Convicted of Wire Fraud and Money Laundering in Connection with Marketing and Sale of AML Bitcoin ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...